Ticagrelor inhibits platelet-tumor cell interactions and metastasis in human and murine breast cancer.

about

Ticagrelor inhibits platelet-tumor cell interactions and metastasis in human and murine breast cancer.

Item

http://www.wikidata.org/entity/Q48265369

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Ticagrelor inhibits platelet-t ...... uman and murine breast cancer.

@en

Ticagrelor inhibits platelet-t ...... uman and murine breast cancer.

@nl

type

Item

label

Ticagrelor inhibits platelet-t ...... uman and murine breast cancer.

@en

Ticagrelor inhibits platelet-t ...... uman and murine breast cancer.

@nl

prefLabel

Ticagrelor inhibits platelet-t ...... uman and murine breast cancer.

@en

Ticagrelor inhibits platelet-t ...... uman and murine breast cancer.

@nl

P1476

Ticagrelor inhibits platelet-t ...... human and murine breast cancer

@en

P2093

Alison J Gareau

http://www.w3.org/2001/XMLSchema#string

Brent Johnston

http://www.w3.org/2001/XMLSchema#string

Colin Brien

http://www.w3.org/2001/XMLSchema#string

Robert S Liwski

http://www.w3.org/2001/XMLSchema#string

Simon Gebremeskel

http://www.w3.org/2001/XMLSchema#string

P2860

Platelet integrin α6β1 controls lung metastasis through direct binding to cancer cell-derived ADAM9.

Platelet P2Y12 is involved in murine pulmonary metastasis

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

Presence of intratumoral platelets is associated with tumor vessel structure and metastasis

Platelets guide the formation of early metastatic niches.

P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer

Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials.

Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials.

Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells

Choosing the right cell line for breast cancer research

P2888

s10585-018-9874-1

P304

25-35

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10585-018-9874-1

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael Bezuhly

P577

2018-01-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29322294

http://www.w3.org/2001/XMLSchema#string